Patents by Inventor Attila Lorincz

Attila Lorincz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detection of nucleic acids by type-specific hybrid capture method
    Publication number: 20040214302
    Abstract: Target-specific hybrid capture (TSHC) provides a nucleic acid detection method that is not only rapid and sensitive, but is also highly specific and capable of discriminating highly homologous nucleic acid target sequences. The method produces DNA/RNA hybrids which can be detected by a variety of methods.
    Type: Application
    Filed: April 4, 2003
    Publication date: October 28, 2004
    Inventors: James Anthony, Attila Lorincz, Inna Williams, John Troy, Yanlin Tang
  • Non-radioactive hybridization assay and kit
    Publication number: 20020012936
    Abstract: A non-radioactive hybridization assay and kit for the detection of genetic defects, microbial infections or viral infections, such as human papillomavirus. A test sample is treated with a base and incubated with nucleic acid probes, diluted in a neutralizing buffer, specific for target nucleic acids. The hybrids are captured onto a solid phase coated with an anti-hybrid antibody, unhybridized probe is eliminated, and the bound hybrid detected.
    Type: Application
    Filed: May 7, 2001
    Publication date: January 31, 2002
    Inventors: Attila Lorincz, Sharon Challberg, Allison Cullen, Chaka Impraim, Hiam Salim, James G. Lazar
  • Non-radioactive hybridization assay and kit
    Patent number: 6228578
    Abstract: A non-radioactive hybridization assay and kit for the detection of genetic defects, microbial infections or viral infections, such as human papillomavirus. A test sample is treated with a base and incubated with nucleic acid probes, diluted in a neutralizing buffer, specific for target nucleic acids. The hybrids are captured onto a solid phase coated with an anti-hybrid antibody, unhybridized probe is eliminated, and the bound hybrid detected.
    Type: Grant
    Filed: January 18, 1994
    Date of Patent: May 8, 2001
    Assignee: Digene Corporation
    Inventors: Chaka Impraim, Sharon Challberg, Attila Lörincz, Allison Cullen
  • Detection of hepatitis B virus
    Patent number: 6225053
    Abstract: An improved assay disclosed for detecting viral nucleic acid sequences. The improvement involves concentration viral particles from a biological sample by centrifugation. Once concentrated, the nucleic acid molecules in the viral particles can be manipulated or detected using any suitable procedure. Many such procedure are know and can be used with the concentrated viral nucleic acid molecules. Preferably, the concentrated viral nucleic acid is detected using a detection assay.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: May 1, 2001
    Assignee: Digene Corporation
    Inventors: Mariana Garcia, Ming Chan, Attila Lörincz